Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma

Clinical trial NCT01012297 · TERMINATED

Trial details

NCT number: NCT01012297
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Uterine Corpus Sarcoma Stage IIIA Uterine Sarcoma Stage IIIB Uterine Sarcoma Stage IIIC Uterine Sarcoma Stage IVA Uterine Sarcoma Stage IVB Uterine Sarcoma Uterine Corpus Leiomyosarcoma

Start date: 2009-11-01
Primary completion: 2015-09-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.